Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

SGPSGP
2 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in SPYGLASS PHARMA INC

Yes. JPMorgan Chase holds 629,739 shares of SGP (Spyglass Pharma), worth $13.6M, as of its Q2 2026 13F filing. It increased the position by 52,630 shares (+9.1%) from Q1 2026. JPMorgan Chase has held SGP since Q1 2026, across 2 quarterly 13F filings.

Current Value

$13.6M

Current Shares

629,739

Total Value Change

+$146,813

Total Shares Change

+52,630

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
629,739
+9.1%
$13.6M0.0%$22.26
31
2026-Q1
New
577,109
-
$13.5M0.0%$26.75
39

Other major holders of SGP: RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used